Fiber-based formulations appear to lower the odds for the disease, non-fiber products seem to raise them
by wgacdctx on Wed Oct 10, 2012 10:16 PM
My name is Caitilin. I'm 22 years old and was diagnosed with CMML-2 this past Friday. I had 19% blasts in my bone marrow and 9% in my blood. I am currently on Day 2 of a clinical trial using Vorinostat, Idarubicin, and Cytarbine. I'm inpatient for this Induction round at MDA and was wondering if anyone else was in the same boat?
by MaryCarol on Mon Oct 15, 2012 08:48 PM
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
If you were considering traveling for cancer treatment, which headline would you find more interesting?
Destination: HOPE. Cancer care that is worth the trip.
Over 84% of our patients travel to our hospital from another state
Neither headline is interesting
We care about your feedback. Let us know how we can improve your CancerCompass experience.